What Is Hypoventilation Syndrome? Causes and Symptoms

Hypoventilation syndrome is a condition in which you breathe too shallowly or too slowly, allowing carbon dioxide to build up in your blood to abnormal levels. The defining marker is a carbon dioxide level above 45 mmHg on a blood gas test taken while you’re awake. Several distinct conditions fall under this umbrella, but they all share the same core problem: your body isn’t moving enough air in and out of your lungs to keep blood gases in balance.

How Normal Breathing Keeps CO2 in Check

Every time you exhale, you’re clearing carbon dioxide, a waste product of metabolism, from your bloodstream. Specialized sensors in your brainstem constantly monitor CO2 levels and adjust your breathing rate and depth to keep things balanced. When CO2 rises even slightly, these sensors signal your breathing muscles to work harder.

In hypoventilation syndrome, this system breaks down. Either the sensors themselves are impaired, the signals don’t reach the breathing muscles effectively, or the mechanics of breathing are physically restricted. The result is the same: CO2 accumulates, oxygen drops, and your body operates in a state of chronic imbalance that slowly damages the heart and other organs.

Obesity Hypoventilation Syndrome: The Most Common Form

The most frequently diagnosed type is obesity hypoventilation syndrome (OHS), sometimes called Pickwickian syndrome. It’s defined by three criteria: a BMI of 30 or higher, daytime carbon dioxide retention (above 45 mmHg), and the absence of another lung, nerve, or muscle disease that would explain the problem. Roughly 0.15 to 0.4% of the general population has OHS, but among people already diagnosed with sleep-disordered breathing, the rate jumps to 10 to 30%.

Excess weight, particularly around the chest and abdomen, physically restricts how much the lungs can expand. Over time, the brain’s CO2 sensors become dulled. They stop responding as aggressively to rising carbon dioxide levels, so breathing stays shallow even as CO2 climbs. Most people with OHS also have obstructive sleep apnea, which worsens the picture by repeatedly blocking the airway during sleep. The classic patient is an obese middle-aged man with a BMI of 35 or higher, though the condition affects women as well.

Congenital Central Hypoventilation Syndrome

A rarer form, congenital central hypoventilation syndrome (CCHS), is caused by a mutation in the PHOX2B gene. This gene directs the development of nerve cells during fetal growth, including a small cluster of brainstem neurons that serve as the body’s primary CO2 sensors. When these neurons fail to develop properly, the brain essentially loses its ability to detect rising carbon dioxide.

People with CCHS can breathe relatively normally while awake, because wakefulness itself provides enough stimulation to keep breathing going. Sleep removes that backup system, and breathing can become dangerously shallow or stop altogether. In milder cases, some ability to increase breathing during exercise remains. CCHS is typically diagnosed in infancy, but milder mutations occasionally go undetected until later in life. Most cases arise from a new, spontaneous mutation rather than being inherited from a parent.

Symptoms of Chronic CO2 Buildup

Because hypoventilation often worsens gradually, symptoms can develop so slowly that people don’t recognize them. The most common complaints are excessive daytime sleepiness, morning headaches (caused by CO2 building up overnight), difficulty concentrating, and poor memory. Snoring, witnessed pauses in breathing during sleep, and unrefreshing sleep are also typical, especially when obstructive sleep apnea is present.

As the condition progresses and begins to strain the heart, you may notice shortness of breath with activity, fatigue that doesn’t improve with rest, and swelling in the ankles or lower legs. Some people develop a visibly distended abdomen from fluid accumulation. These later symptoms signal that the right side of the heart is beginning to fail, a complication called cor pulmonale.

What Happens to the Heart Over Time

Chronically low oxygen levels cause the small blood vessels in the lungs to constrict and eventually thicken. This raises the pressure inside the lung circulation, forcing the right side of the heart to pump harder. Over months to years, the right ventricle enlarges and eventually weakens. Signs of this progression include bulging neck veins, an enlarged liver, fluid buildup in the abdomen, and worsening ankle swelling. Exertional chest pain and fainting during physical activity can also occur. These cardiovascular consequences are largely preventable with early treatment of the underlying hypoventilation.

How It’s Diagnosed

The single most important test is an arterial blood gas, a blood draw from an artery (usually the wrist) that directly measures carbon dioxide and oxygen levels. A daytime CO2 reading above 45 mmHg while breathing room air confirms hypoventilation. The blood will also show an elevated bicarbonate level, which is the body’s attempt to buffer the excess acid created by chronic CO2 retention. That elevated bicarbonate is a clue that the problem has been present for weeks or longer, not just hours.

An overnight sleep study with CO2 monitoring provides additional information. During the study, sensors track your breathing patterns, oxygen levels, and carbon dioxide levels throughout the night. CO2 can be measured through a small nasal cannula that samples exhaled air or through a sensor placed on the skin. The sleep study also identifies whether obstructive sleep apnea is contributing, and how much time you spend with dangerously elevated CO2 during sleep. For OHS specifically, the diagnosis requires ruling out other explanations like chronic lung disease, neuromuscular disorders, or chest wall deformities through imaging and sometimes additional lung function testing.

Treatment With Breathing Support

The primary treatment for hypoventilation syndrome is noninvasive ventilation, a machine that delivers pressurized air through a mask worn during sleep. The specific type depends on what’s driving the hypoventilation.

For people with OHS who also have significant obstructive sleep apnea, continuous positive airway pressure (CPAP) is often tried first. CPAP delivers a steady stream of air that keeps the airway open, and for some patients, simply eliminating the obstructive events is enough to improve CO2 levels. When CPAP alone doesn’t correct the hypoventilation, or when the primary problem is shallow breathing rather than airway obstruction, bilevel positive airway pressure (BiPAP) is used instead. BiPAP delivers higher pressure when you inhale and lower pressure when you exhale, effectively doing some of the breathing work for you. For patients who are acutely ill with worsening CO2 levels, BiPAP is typically the first choice.

A small number of people don’t tolerate or respond to BiPAP. For them, a hybrid mode called volume-assured pressure support automatically adjusts to guarantee a minimum amount of air enters the lungs with each breath. In congenital cases, children often require ventilatory support every night for life, and some need a surgically implanted diaphragm pacemaker that electrically stimulates the breathing muscle.

Weight Loss and Long-Term Outlook

For OHS, weight loss is the only intervention that addresses the root cause. Even a moderate reduction in body weight can meaningfully improve lung function and CO2 levels. Bariatric surgery has been shown to resolve OHS in many patients, sometimes allowing them to stop using nighttime ventilation entirely. However, weight loss takes time, and breathing support remains essential in the interim to prevent cardiovascular damage.

Untreated hypoventilation syndrome carries a significantly higher risk of hospitalization, heart failure, and death compared to simple obesity or obstructive sleep apnea alone. With consistent use of nighttime ventilation, CO2 levels typically normalize within weeks to months, daytime sleepiness improves, and the strain on the heart begins to reverse. The key is recognizing the condition early, before the heart and pulmonary blood vessels have sustained permanent damage.